WB
Western blot analysis using GLUT1 antibody against A431 (1) cell lysate.
IHC
Immunohistochemical analysis of paraffin-embedded Human lung cancer tissues using GLUT1 antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human breast cancer tissues using GLUT1 antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human lung kidney tissues using GLUT1 antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human ovarian cancer tissues using GLUT1 antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human renal carcinoma tissues using GLUT1 antibody with DAB staining.
WB
(g–p) Results from western blot analysis showed that apelin-13 promoted the expression of GLUT1, PKM2, LDHA, MCT1, and MCT4 in dose- and time-dependent manners for 24 hr (data were presented as mean ± SEM, n = 3–4; *p < 0.05, **p < 0.01, and ***p < 0.001 vs. control).
WB
(d–h) Western blot analysis showed that apelin-13 promoted the expression of GLUT1, PKM2, LDHA, MCT1, and MCT4, however, F13A reversed apelin-13-induced GLUT1, PKM2, LDHA, MCT1, and MCT4 expression (data were presented as mean ± SEM, n = 4–5; *p < 0.05, **p < 0.01, and ***p < 0.001 vs.
WB
Western blot analysis using GLUT1 antibody against Rat stomach(1) tissue.